AI toxicity & ADMET predictionconfirmed
Deep Origin
AI and simulation platform for drug discovery, including ADMET-NOW prediction models.
Notable
Leads the PREDICTS consortium under an ARPA-H CATALYST contract of up to $31.7M (Dec 2025).
Related deals
- Dec 4, 2025Government funding, ARPA-H CATALYSTPREDICTS consortium to build in silico and ex vivo models that predict drug safety and dosing before clinical trials.up to $31.7Mdeeporigin.com(opens in new tab)
Related updates
No related news yet.